ID

13604

Descrizione

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00513305

collegamento

https://clinicaltrials.gov/show/NCT00513305

Keywords

versioni (1)
  1. 19/02/16 19/02/16 -
Titolare del copyright

CC BY-NC 3.0

Caricato su

19 febbraio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Acute Myeloid Leukemia NCT00513305

Inglese

Eligibility Acute Myeloid Leukemia NCT00513305

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient has confirmed acute myeloid leukemia (aml).
Descrizione

the patient has confirmed acute myeloid leukemia (aml).

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023467
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
Descrizione

the patient is unwilling or unable to tolerate conventional induction chemotherapy.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
Descrizione

the patient has no comorbid conditions that would limit life expectancy to less than 3 months.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
patient must meet specific laboratory parameters for study inclusion.
Descrizione

patient must meet specific laboratory parameters for study inclusion.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022885
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
Descrizione

the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205156
previous treatment with low-dose cytarabine is not permitted.
Descrizione

previous treatment with low-dose cytarabine is not permitted.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0010711
the patient has a qt interval outside of the protocol-specified range.
Descrizione

the patient has a qt interval outside of the protocol-specified range.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0429028
the patient has laboratory values outside of protocol-specified ranges.
Descrizione

the patient has laboratory values outside of protocol-specified ranges.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022885
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Descrizione

the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C0851346
UMLS CUI [3]
C1875319
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
Descrizione

the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009488
the patient has known central nervous system involvement with aml.
Descrizione

the patient has known central nervous system involvement with aml.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0449389
Ritorna all'inizio della pagina

Similar models

Eligibility Acute Myeloid Leukemia NCT00513305

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
acute myeloid leukemia
Item
the patient has confirmed acute myeloid leukemia (aml).
boolean
C0023467 (UMLS CUI [1])
conventional induction chemotherapy
Item
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
boolean
C0392920 (UMLS CUI [1])
life expectancy
Item
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
boolean
C0023671 (UMLS CUI [1])
laboratory parameters
Item
patient must meet specific laboratory parameters for study inclusion.
boolean
C0022885 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy
Item
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
boolean
C0392920 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
cytarabine
Item
previous treatment with low-dose cytarabine is not permitted.
boolean
C0010711 (UMLS CUI [1])
qt interval
Item
the patient has a qt interval outside of the protocol-specified range.
boolean
C0429028 (UMLS CUI [1])
laboratory values
Item
the patient has laboratory values outside of protocol-specified ranges.
boolean
C0022885 (UMLS CUI [1])
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Item
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
boolean
C0677881 (UMLS CUI [1])
C0851346 (UMLS CUI [2])
C1875319 (UMLS CUI [3])
comorbidity
Item
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
boolean
C0009488 (UMLS CUI [1])
central nervous system involvement
Item
the patient has known central nervous system involvement with aml.
boolean
C0023467 (UMLS CUI [1,1])
C0449389 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial